Holder snapshot 6 signals
Share change
+341,883
SEC-reported price per share
$6.60
Number of holders
20
Value change
+$1,428,993
Number of buys
12
Number of sells
7
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
4,807,682

Security key

74907L409

Report period

Q1 2026

Institutions

20

Top holders

10

Ownership snapshot

Top reported holders of QNRX - Quoin Pharmaceuticals Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Stonepine Capital Managem...
Disclosed value leader
Stonepine Capital Managem...
Comparable rows
7/15
Latest evidence
26 Mar 2026
3/4/5 13D/G 13F Lead comparable stake: 11% 8 rows are not safely comparable across share classes. 13D/G row: Stonepine Capital Management, LLC Showing 1-6 of 15 holder rows.

Quick read

Stonepine Capital Management, LLC leads the comparable SEC ownership view at 11%.

7 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Stonepine Capital Management, LLC's linked filing trail.
Comparable ownership Top 5
Stonepine Capital Management, LLC 11%
Woodline Partners LP 9.5%
Resolute Capital Asset Partners LLC 8.5%
ARMISTICE CAPITAL, LLC 5%
ADAR1 Capital Management, LLC 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Stonepine Capital Management, LLC
3/4/5 13D/G 13F
10%+ Owner · Company
11%
Reported 13D/G · 29 Jan 2026
$47,201,973
3,271,100 shares
— 26 Mar 2026
Woodline Partners LP
13D/G 13F
Company
9.5%
Reported 13D/G · 31 Dec 2025
$38,298,838
2,785,370 shares
$0 31 Dec 2025
Resolute Capital Asset Partners LLC
13D/G 13F
Company
8.5%
Reported 13D/G · 10 Oct 2025
$671,000
50,000 shares
$0 10 Oct 2025
ARMISTICE CAPITAL, LLC
13D/G
5%
Reported 13D/G · 31 Mar 2025
$7,049,313
1,081,183 shares
$0 31 Mar 2025
ADAR1 Capital Management, LLC
13F 13D/G
Company · ADAR1 Capital Management GP, LLC
4.9%
Reported 13D/G · 31 Mar 2026
$840,259
58,230 shares
— 31 Dec 2025
Denise P. Carter
13D/G
Denise Carter
4.9%
Reported 13D/G · 27 Jan 2025
$244,202
939,238 shares
+$82,374 27 Jan 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
20
Shares
1,184,710
Rows available
20
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
18
Q1 2026 holders
20
Holder diff
2
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .